Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

View source ↗

Summary

The NAVAH study at the University of Oklahoma is recruiting to evaluate navigator-assisted hypofractionation aimed at facilitating completion of radiation thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oklahoma | Conditions: Breast Cancer, Prostate Cancer | Status: RECRUITING